Young III James W MD is categorized under Family Practice Doctors in Eustis, FL and active since 2005.
Young III James W MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact James Young III at the company’s single location by writing to 801 Northshore Drive, Eustis, Florida FL 32726 or by phoning (352) 357-6786. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Young III James W MD |
| Contact Person: | James Young III |
| Address: | 801 Northshore Drive, Eustis, Florida 32726 |
| Phone Number: | (352) 357-6786 |
| Website Address: | prostateevaluation.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Young III James W MD was started in 2005 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact James Young III for inquiries that concern Young III James W MD by calling the company number (352) 357-6786, as your correspondence is most welcome. Additionally, the physical location of the single location of Young III James W MD can be found at the coordinates 28.860687,-81.687286 as well as the street address 801 Northshore Drive in Eustis, Florida 32726.
For its online presence, you may visit Young III James W MD’s website at prostateevaluation.com and engage with its social media outlets through on Twitter and on Facebook.